Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD274 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZBTB11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | COG2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BRD3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PKD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | UBE2J1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TM6SF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | IQSEC1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | ASXL2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ARG1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |